|
WO2021054535A2
|
|
Stabilized efinaconazole-containing pharmaceutical composition comprising combination of chelating agent, antioxidant, and acid
|
|
WO2021054531A2
|
|
Stabilized efinaconazole-containing pharmaceutical composition comprising antioxidant
|
|
WO2021054533A2
|
|
Stabilized eficonazole-containing pharmaceutical composition comprising sorbic acid as acid
|
|
KR20200140681A
|
|
Pharmaceutical compositions for topical administration in the form of solution comprising efinaconazole
|
|
KR20210032869A
|
|
Stabilized efinaconazole-containing pharmaceutical compositions comprising a combination of chelating agent, antioxidant, and acid
|
|
KR20210032867A
|
|
Stabilized efinaconazole-containing pharmaceutical compositions comprising an antioxidant
|
|
KR20210032868A
|
|
Stabilized efinaconazole-containing pharmaceutical compositions comprising sorbic acid as an acid
|
|
KR20210032662A
|
|
Stabilized efinaconazole-containing pharmaceutical compositions comprising a chelating agent
|
|
KR20210032672A
|
|
Stabilized pharmaceutical compositions comprising efinaconazole
|
|
KR20210032665A
|
|
Stabilized efinaconazole-containing pharmaceutical compositions comprising a combination of chelating agent and acid
|
|
KR102060546B1
|
|
Pharmaceutical compositions for topical administration in the form of solution comprising efinaconazole
|
